Fruzaqla (fruquintinib) - Takeda
Fruquintinib Monotherapy Versus Fruquintinib Combined with Chemotherapy in Patients with Refractory Metastatic Colorectal Cancer: A Real-World Retrospective Cohort Study (ESMO Asia 2026) - Oct 1, 2026 - Abstract #201P; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available 
Metastases • Monotherapy • Real-world • Real-world evidence • Retrospective data • Colorectal Cancer • Oncology • Solid Tumor
https://cslide.ctimeetingtech.com/asia2026/attendee/confcal/print/presentation/704
 
Jen Pei Huang; Hao-Wei Teng
 
Oct 1, 2026
 
Prev Next